Preclinical News and Research

RSS
New treatment for the pediatric eye cancer retinoblastoma

New treatment for the pediatric eye cancer retinoblastoma

Myriad Genetics nears completion of antithrombin drug trial

Myriad Genetics nears completion of antithrombin drug trial

Johns Hopkins awarded $12 million to study how stem cell therapies can be used to treat hearts damaged by heart attack

Johns Hopkins awarded $12 million to study how stem cell therapies can be used to treat hearts damaged by heart attack

New treatment option for chronic sinusitis

New treatment option for chronic sinusitis

Microchip system aims to reduce the number of animals used in the development of new drugs

Microchip system aims to reduce the number of animals used in the development of new drugs

Neurologix announces positive interim results of gene therapy clinical trial for patients with Parkinson's disease

Neurologix announces positive interim results of gene therapy clinical trial for patients with Parkinson's disease

First true animal model for psoriasis

First true animal model for psoriasis

Molecular pathway in mice that makes prostate cells vulnerable to cancer-causing oxygen damage

Molecular pathway in mice that makes prostate cells vulnerable to cancer-causing oxygen damage

RNAi therapeutic successful for treatment of SARS respiratory virus in Rhesus Macaque

RNAi therapeutic successful for treatment of SARS respiratory virus in Rhesus Macaque

Stressgen granted new U.S. patent for treatment of Hepatitis B

Stressgen granted new U.S. patent for treatment of Hepatitis B

Design of wide-spectrum inhibitors targeting coronavirus main proteases

Design of wide-spectrum inhibitors targeting coronavirus main proteases

Metabolic Syndrome, a map of the cardiovascular damage

Metabolic Syndrome, a map of the cardiovascular damage

Potential new way to fight HIV

Potential new way to fight HIV

New vaccine protects more effectively against tuberculosis

New vaccine protects more effectively against tuberculosis

First clinical trial of a biologic nanoparticle designed to give back to cancer patients the tumor-busting gene they have lost

First clinical trial of a biologic nanoparticle designed to give back to cancer patients the tumor-busting gene they have lost

Experimental immunusuppressant drug preserves transplanted kidneys

Experimental immunusuppressant drug preserves transplanted kidneys

Lorus identifies novel class of lead drug candidates from small molecule anticancer program

Lorus identifies novel class of lead drug candidates from small molecule anticancer program

Disease modifying activity of 2ME2 demonstrated in preclinical rheumatoid arthritis studies

Disease modifying activity of 2ME2 demonstrated in preclinical rheumatoid arthritis studies

Non-invasive imaging may help predict type 1 diabetes and response to treatment in humans

Non-invasive imaging may help predict type 1 diabetes and response to treatment in humans

Combined gene therapy eliminates glioblastoma multiforme in lab studies

Combined gene therapy eliminates glioblastoma multiforme in lab studies

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.